PPID study wins top veterinary award
Groundbreaking research into pituitary pars intermedia dysfunction (PPID), also known as Equine Cushing’s disease, conducted by international veterinary research collaborators, in conjunction with SPILLERS, has been recognised with a major veterinary accolade.
Lead author Nicolas Galinelli received The Peter Rossdale Equine Veterinary Journal (EVJ) Open Award from Her Royal Highness The Princess Royal during the BEVA Congress last month. The award honours research that significantly advances equine clinical practice or scientific understanding.
The study — Effect of pergolide treatment on insulin dysregulation in horses and ponies with pituitary pars intermedia dysfunction — was carried out by the University of Melbourne in partnership with SPILLERS, Boehringer Ingelheim Vetmedica, Queensland University of Technology and the Australian Research Council. Key findings included:
- Pergolide mesylate, the most common PPID treatment, may help reduce insulin responses after feeding.
- Medication alone did not normalise insulin levels, underlining the importance of a low-sugar, low-starch diet.
“Many congratulations to Nicolas Galinelli on winning this highly regarded award,” said Sarah Nelson, Product Manager at Mars Horsecare, home of the SPILLERS brand. “We are very proud to be involved with these important studies.”
The paper is available with open access via the Equine Veterinary Journal: beva.onlinelibrary.wiley.com/doi/10.1111/evj.14468